Dr Reddys Laboratories reports 3-fold rise in Q3 net profit

14 Feb 2013 Evaluate

Dr Reddys Laboratories has reported results for third quarter ended December 31, 2012.

The company has posted growth of over 3-fold in its net profit at Rs 346.64 crore for the quarter as compared to Rs 108.03 crore for the same quarter in the previous year. Total income from operation of the company has increased by 33.97% at Rs 2186.30 crore for quarter under review as compared to Rs 1631.86 crore for the quarter ended December 31, 2011.

The company, on consolidated basis, posted a fall of 29.17% in its net profit at Rs 363.31 crore for the quarter as compared to Rs 512.96 crore for the same quarter in the previous year. However, total income of the company increased by 3.69% at Rs 2888.47 crore for quarter under review as compared to Rs 2785.67 crore for the quarter ended December 31, 2011.

Dr. Reddys Lab Share Price

1272.70 -2.35 (-0.18%)
08-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×